Autres langues SK Discovery Co., Ltd.

Actions

A006120

KR7006120000

Cours en clôture Korea S.E. Autres places de cotation 00:00:00 17/05/2024			Varia. 5j.	Varia. 1 janv.
42 950 ^KRW	-1,26 %		-3,05 %	+9,57 %

11/03	SK Discovery Co. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
05/03	SK Discovery Co. (KOSE:A006120) annonce un rachat d'actions pour une valeur de 20 000 millions de KRW.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

SK Discovery : chemicals Wraps Up ChinaPlas Triumphantly··· Unveils Blueprint for Circular Recycle™ and Solutions	13/05
SK Discovery : "Chinaplas 2024 Focuses on "Circular Economy"… SK Chemicals Introduces ‘Circular Recycle’ Technology and Solutions	13/05
SK Discovery : chemicals, Dongsung Chemical, and Black Yak Collaborate on Commercializing Sustainable Footwear	22/04
SK Discovery : D&D signs MOU with the largest global co-living provider Habyt to strengthen residential business	17/04
SK Discovery : chemicals Achieves Upgraded “AA” MSCI ESG Rating	08/04
SK Discovery Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	11/03
SK Discovery Co., Ltd. announces an Equity Buyback for KRW 20,000 million worth of its shares.	05/03
SK Discovery Co., Ltd. authorizes a Buyback Plan.	05/03
Tranche Update on SK Discovery Co., Ltd.'s Equity Buyback Plan announced on July 21, 2023.	22/01
Tranche Update on SK Discovery Co., Ltd.'s Equity Buyback Plan announced on July 21, 2023.	22/01
SK Discovery Co., Ltd.'s Equity Buyback announced on July 21, 2023, has expired with 252,000 shares, representing 1.28% for KRW 9,963.12 million.	22/01
SK Discovery : Administration of Novavax’s Updated COVID-19 Vaccine Will Begin in Korea on December 18	12/12
SK Discovery : bioscience and Sanofi Initiate Submission of Phase III Study Investigational New Drug Amendment to the U.S. FDA of 21-Valent Pneumococcal Conjugate Vaccine Candidate	11/12
SK Group Boss' Cousin to Head SK SUPEX Council	06/12
SK Discovery : bioscience Expands L HOUSE for Preparing Commercialization of Next-Generation Pneumococcal Vaccine	28/11
SK Discovery : bioscience and Hilleman Laboratories Announce Joint Development of Second -Generation Zaire Ebola Virus Vaccine	22/11
SK Discovery Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Tranche Update on SK Discovery Co., Ltd.'s Equity Buyback Plan announced on July 21, 2023.	25/10/23
SK Discovery : chemicals, Storing Music in Circular Recycled Plastics	19/10/23
SK Discovery : “Packaging Sustainability in the Global Cosmetics Market” SK chemicals Partners with The Estee Lauder Companies	17/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues SK Discovery Co., Ltd.

Actions

A006120

KR7006120000

Autres langues

Filtres